Assistance Publique - Hôpitaux De Paris
Clinical trials sponsored by Assistance Publique - Hôpitaux De Paris, explained in plain language.
-
New hope for kids with Arthritis-Related eye problems when standard treatments fail
Disease control CompletedThis study tested whether the drug adalimumab could reduce eye inflammation in children with juvenile arthritis whose eye problems weren't helped by standard steroid drops and methotrexate. For the first two months, some children received adalimumab while others received a placeb…
Phase: PHASE2, PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 23, 2026 12:44 UTC
-
New hope for lung transplant patients facing chronic rejection
Disease control CompletedThis study tested whether the drug nintedanib could slow the decline of lung function in transplant patients who develop chronic rejection. Fifty-eight lung transplant recipients with early-stage rejection were randomly assigned to receive either nintedanib or a placebo pill for …
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
Can a simple text stop your next broken bone?
Disease control CompletedThis study tested whether sending text message reminders could help patients get important follow-up care after breaking a bone. Researchers enrolled 97 adults over 50 who came to the emergency room with a low-trauma fracture. One group received standard advice, while another got…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
AI eye scanner could predict diabetic blindness risk
Diagnosis CompletedThis study tested an artificial intelligence (AI) system designed to help eye doctors predict whether a patient's diabetic retinopathy will get worse. Researchers followed over 3,000 diabetic patients for about 2 years, collecting retinal scans and medical data to train and valid…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Apr 06, 2026 14:18 UTC
-
Jaw surgery may ease sleep apnea symptoms, small study finds
Symptom relief CompletedThis study tested whether a jaw-widening surgery (surgically assisted maxillary expansion) could improve quality of life in 9 adults with obstructive sleep apnea. Participants filled out sleep and quality-of-life questionnaires before surgery and again 3 months and 1 year after. …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Apr 26, 2026 20:01 UTC
-
Immune booster shows promise for bipolar depression
Symptom relief CompletedThis study tested a low dose of interleukin-2 (IL-2) in 14 people with bipolar disorder who were currently depressed. The goal was to see if the treatment could increase certain immune cells (Tregs) and improve mood. Participants continued their usual mood stabilizers or antidepr…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Apr 24, 2026 16:06 UTC
-
Extra drug tested to stop kids from getting sick after surgery
Symptom relief CompletedThis study tested whether adding a third anti-nausea drug (droperidol) to the standard two-drug combination works better at preventing vomiting after surgery in children. Researchers enrolled 322 children aged 3-18 who were at high risk for post-surgery vomiting. They compared th…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Apr 20, 2026 16:17 UTC
-
Immune-Calming drug tested to tame seasonal allergies
Symptom relief CompletedThis study tested whether a drug called ILT-101 (low-dose IL-2) could reduce allergy symptoms in people sensitive to birch pollen. The drug aims to boost the body's natural 'peacekeeper' immune cells to calm down the allergic reaction. Twenty-four adults with confirmed birch poll…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Apr 13, 2026 20:08 UTC
-
Vaginal fluid may reveal preterm birth risk
Knowledge-focused CompletedThis study looked for special molecules in vaginal fluid that could help doctors predict which pregnant women will deliver early. Researchers studied 238 women, including those with preterm labor and healthy pregnant women. The goal is to find a simple test to catch preterm birth…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:35 UTC
-
Hidden danger: low blood sugar in kids with adrenal gland disorder
Knowledge-focused CompletedThis study looked at how often low blood sugar (hypoglycemia) happens in children aged 6 months to 6 years with congenital adrenal insufficiency, a condition where the body doesn't make enough cortisol. Even with standard treatment, these children may still be at risk. Researcher…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:19 UTC
-
Scientists engineer 'smarter' IL-2 to tame overactive immune systems
Knowledge-focused CompletedThis study tested specially engineered versions of a natural immune protein (IL-2) in blood samples from 67 people with autoimmune or inflammatory diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal was to see if these modified proteins could selectively a…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:18 UTC
-
Doctors test better way to measure kidney health in critically ill patients
Knowledge-focused CompletedThis study compared two different methods for measuring kidney function in critically ill ICU patients whose kidneys work unusually fast. Researchers tested 90 ICU patients to see if a newer test using a special dye (iohexol) gives more accurate results than the standard creatini…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 22, 2026 15:58 UTC